Abstract
The equine species, including horses and ponies, can develop myopathy associated with stress, exercise, or general anesthesia. A variety of possible causes exist, and increasing evidence indicates that malignant hyperthermia (MH) plays a role. Identification of MH susceptible (MHS) horses is important to the horse industry from both a performance and breeding standpoint, to the equine anesthesiologist, and for basic research as a new and potentially useful experimental model for further study of MH and its species variations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Klein LV (1975) Case report: A hot horse. Vet Anesth 3: 41–42
Manley SV, Keliy AB, Hodgson D (1983) Malignant hyperthermia-like reactions in three anesthetized horses. J Am Vet Med Assoc 183: 85–89
Riedesel D, Hildebrand SV (1985) Unusual response following use of succinylcholine in a horse anesthetized with halothane. J Am Vet Med Assoc 187: 507
Waldron-Mease E, Klein LV, Rosenberg H, Leitch M (1981) Malignant hyperthermia in a halothane anesthetized horse. J Am Vet Med Assoc 179: 896
Trimm CM, Mason J (1973) Post-anaesthetic forelimb lameness in horses. Equine Vet J 5: 71–76
Steffey EP, Farver T, Zinkl J, Wheat JD, Meagher DM, Brown MP (1980) Alterations in horse blood cell count and biochemical values after halothane anesthesia. Am J Vet Res 41: 934–939
Lindsay W, McDonell W, Bignell W (1980) Equine postanesthetic forelimb lameness: Intracompartmental muscle pressure changes and biochemical patterns. Am J Vet Res 41: 1919–1924
Heath RB, Redder J, Stashak T, Shaw R (1972) Protecting and positioning the equine surgical patient. Vet Med Small Anim Clin 65: 1241–1245
Grandy JL, Steffey EP, Hodgson D, Woliner M (1987) The relationship between arterial hypotension during halothane anesthesia and the development of equine post anesthetic myopathy. Am J Vet Res 48: 192–197
Weaver BMQ, Staddon GE (1984) Muscle perfusion in the horse. Eq Vet J 16: 66–68
Nelson TE, Flewellen EH, Gloyna DF (1983) Spectrum of susceptibility to malignant hyperthermia—Diagnostic dilemma. Anesth Analg 62: 545–552
Gronert GA, Thompson RL, Onofrio BM (1980) Human malignant hyperthermia awake episodes and correction by dantrolene. Anesth Analg 59: 377–378
Beldavs J, Small V, Cooper DA, Britt BA (1971) Postoperative malignant hyperthermia: A case report. Can Anaesth Soc J 18: 202–211
Kalow W, Britt BA, Richter, A (1977) The caffeine test of isolated human muscle in relation to malignant hyperthermia. Can Anaesth Soc J 24: 678–694
Huckell VF, Stanloff HM, McLoughlin PR, Britt BA, Morch JE (1978) Cardiovascular manifestations of normothermic malignant hyperthermia, in Aldrete JA, Britt BA (eds) Proceedings Second International Symposium on Malignant Hyperthermia, Denver, 1977. New York: Grune & Stratton, pp 373–377
Klein L (1978) A review of 50 cases of post-operative myopathy in the horse — Intrinsic and management factors affecting risk. Am Assoc Eq Pract Proc 24: 89–94
Johnson BD, Heath RB, Bowman B, Phillips RW, Rich LD, Voss JL (1978) Serum chemistry changes in horses during anesthesia. J Eq Med Surg 2:109–123
Snow DH, Kerr MG, Nimmo MA, Abbott EM (1982) Alterations in blood, sweat, urine and muscle composition during prolonged exercise in the horse. Vet Rec 110: 377–384
Koterba A, Carlson GP (1982) Acid-base and electrolyte alterations in horses with exertional rhabdomyolysis. J Am Vet Med Assoc 180: 303–306
Cardinet GH, Littrell JF, Freedland RA (1967) Comparative investigations of serum creatinine phosphokinase and glutamic-oxalocacetate transaminase activities in equine paralytic myoglobinuria. Res Vet Sci 8: 219–226
Waldron-Mease E (1979) Hypothyroidism and myopathy in racing thoroughbreds and standardbreds. Eq J Med Surg 3: 124–128
Rosenberg H, Waldron-Mease E (1977) Malignant hyperpyrexia in horses: Anesthetic sensitivity proven by muscle biopsy. Sci Abstr Am Soc Anesth, pp 333–334
Waldron-Mease E (1978) Correlation of postoperative and exercise-induced equine myopathy with the defect malignant hyperthermia. Am Assoc Eq Pract Proc 24: 95–97
Waldron-Mease E (1979) Update on prophylaxis of tying-up using dantrolene. Am Assoc Eq Pract Proc 25: 379
Waldron-Mease E, Rosenberg H (1979) Postanesthetic myositis in the horse associated with in vitro malignant hyperthermia susceptibility. Vet Sci Comm 3: 45–50
Short CE, White KK (1977) Anesthetic/surgical stress-induced myopathy (myosites). Part I: Clinical occurrences. Am Assoc Eq Pract Proc 24: 101–106
Gronert GA, Mansfield E, Theye RA (1978) Rapidly soluble dantrolene for intravenous use, in Aldrete JA, Britt BA (eds) Proceedings Second International Symposium on Malignant Hyperthermia, Denver 1977. New York: Grune & Stratton, pp 535–536
Gronert GA, Mansfield E, Theye RA (1978) Rapidly soluble dantrolene for intravenous use, in Aldrete JA, Britt BA (eds) Proceedings Second International Symposium on Malignant Hyperthermia, Denver 1977. New York: Grune & Stratton, pp 535–536
Waldron-Mease E (1977) Postoperative muscle damage in horses. J Eq Med Surg 1: 106–110
Hildebrand SV, Howitt GA (1983) Succinylcholine infusion associated with hyperthermia in ponies anesthetized with halothane. Am J Vet Res 44:2280–2284
Hildebrand SV, Arpin D, Howith CA (1985) Development of a technique for biopsy and in vitro contracture testing for malignant hyperthermia in equine muscle. Proceedings, 2nd International Congress of Veterinary Anesthesia. Santa Barbara, CA: Veterinary Practice Publishing Co., pp 168–169
Nelson TE, Denborough MA (1977) Studies on normal human skeletal muscle in relation to the pharmacopathology of malignant hyperpyrexia. Clin Exp Pharmacol Physiol 4: 315–322
Ording H, Ranbler E, Fletcher R (1984) Investigation of malignant hyperthermia in Denmark and Sweden. Br J Anaesth 56: 1183–1189
Ording H, Ranbler E, Fletcher R (1984) Investigation of malignant hyperthermia in Denmark and Sweden. Br J Anaesth 56: 1183–1189
Cardinet GH, Holliday TA (1979) Neuromuscular diseases of domestic animals: A summary of muscle biopsies from 159 cases. Ann NY Acad Sci 317: 290–313
Deuster PA, Bockman EL, Muldoon S (1985) In vitro responses of cat skeletal muscle to halothane and caffeine. J Appl Physiol 58: 521–527
Harriman DGF (1979) Preanesthetic investigation of malignant hyperthermia: Microscopy. Int Anesth Clin 17: 97–117
Gronert GA (1979) Muscle contractures and adenosine triphosphate depletion in porcine malignant hyperthermia. Anesth Analg 58: 367–371
Britt BA, Endrenyi L, Kalow W, Peters P (1976) The adenosine triphosphate ( ATP) depletion test: Comparison with the caffeine contracture test as a method of diagnosing malignant hyperthermia susceptibility. Can Anaesth Soc J 23: 624–635
Allen PD, Ryan JF, Sreter FA, Mabuchi K (1980) Rigid vs non-rigid MH, studies of Ca2+ uptake and actomyosin ATPase. Anesthesiology 53: 5251
Nagarajan K, Fishbein WN, Carlin HM, Pezeshkpour G, Muldoon SM (1985) Frozen section calcium-uptake versus halothane and caffeine contracture tests on human muscle. Anesthesiology 63 (A): 307
Blanck TJJ, Gruener R, Suffecool SL, Thompson M (1981) Calcium uptake by isolated sarcoplasmic reticulum: Examination of halothane inhibition, pH dependence and Ca2+ dependence of normal and malignant hyperthermia human muscle. Anesth Analg 60: 492–98
Maijanen L, Denborough MA (1982) Adenylate kinase and malignant hyperthermia. Br J Anaesth 54: 949–952
Giger U, Kaplan RF (1983) Halothane induced ATP depletion in platelets from patients susceptible to malignant hyperthermia and from controls. Anesthesiology 58: 347–352
Lee MB, Adragna MG, Ewards L (1985) The use of a platelet nucleotide assay as a possible diagnosic test for malignant hyperthermia. Anesthesiology 63: 311–315
Lee MB, Adragna MG, Ewards L (1985) The use of a platelet nucleotide assay as a possible diagnosic test for malignant hyperthermia. Anesthesiology 63: 311–315
Valberg S, Essen-Gustavsson B, Lindholm A, Persson S (1985) Energy metabolism in relation to skeletal muscle fiber properties during treadmill exercise. Eq Vet J 17: 439–444
Valberg S, Essen-Gustavsson B, Lindholm A, Persson S (1985) Energy metabolism in relation to skeletal muscle fiber properties during treadmill exercise. Eq Vet J 17: 439–444
Valberg S, Essen-Gustavsson B, Lindholm A, Persson S (1985) Energy metabolism in relation to skeletal muscle fiber properties during treadmill exercise. Eq Vet J 17: 439–444
Essen-Gustavsson B, Lindholm A (1985) Muscle fiber characteristics of active and inactive standardbred horses. Eq Vet J 17: 434–438
Essen-Gustavsson B, Lindholm A (1985) Muscle fiber characteristics of active and inactive standardbred horses. Eq Vet J 17: 434–438
van den Hoven R, Meijer AEFH, Wensing Th, Breukink HJ (1985) Enzyme histochemical features of equine gluteus muscle fibers. Am J Vet Res 46:1755–1761
van den Hoven R, Wensing Th, Breukink HJ, Meijer AEFH, Kruip TAM (1985) Variation of fiber types in the triceps brachii, longissimus dorsi, gluteus medius, and biceps femoris of horses. Am J Vet Res 46: 939–941
Snow, DH, Guy PS (1980) Muscle fiber composition of a number of limb muscles in different types of horses. Res Vet Sci 28: 137–144
Esson B, Lindholm A, Thornton J (1980) Histochemical properties of muscle fiber types and enzyme activities in skeletal muscles of standard bred trotters of different ages. Eq Vet J 1: 175–180
Taylor AW, Brassard L (1981) Skeletal muscle fiber distribution and area in trained and stalled standardbred horses. Southwest Vet 34: 101–104
Barlow DA, Lloyd JM, Helhake P, Seder JA (1984) Equine muscle fiber types: A histological and histochemical analysis of selected thoroughbred yearlings. J Eq Vet Sci 2: 60–66
Barlow DA, Lloyd JM, Helhake P, Seder JA (1984) Equine muscle fiber types: A histological and histochemical analysis of selected thoroughbred yearlings. J Eq Vet Sci 2: 60–66
Andrews FM, Spurgeon TL, Reed SM (1986) Histochemical changes in skeletal muscle of four male horses with neuromuscular disease. Am J Vet Res 47: 2078–2083
Webb AJ, Gordon CHC (1978) Halothane sensitivity as a field test for stress susceptibility in the pig. Anim Prod 26: 157–168
McGrath CJ, Lee JC, Rempel WE (1984) Halothane testing for malignant hyperthermia in swine: Dose-response effects. Am J Vet Res 45: 1734–1736
Seeler DC, McDonell WN, Basur PK (1983) Halothane and halothane succinylcholine induced malignant hyperthermia (porcine stress syndrome) in a population of Ontario boars. Can J Comp Med 47: 284–290
O’Brien PJ, Mickleson JR, Gronert GA, Louis CF (1985) Malignant hyperthermia susceptibility hypersensitive calcium-induced calcium release mechanism of muscle. Anesthesiology 63: 270
Allen P, Lopez JR, Jones D, Alamo L, Papp L, Sreter FS (1985) Measurements of (Ca2+)i in skeletal muscle of malignant hyperthermia swine. Anesthesiology 63: 270
Cribb PH, Olfart ED, Reynolds FB (1985) The inheritance and prediction of malignant hyperthermia in the dog. Proceedings 2nd International Congress Veterinary Anesthesia. Santa Barbara, CA: Veterinary Practice Publishing Co., pp 170–171
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Hildebrand, S.V. (1988). Horses and Ponies as Animal Models for Malignant Hyperthermia. In: Williams, C.H. (eds) Experimental Malignant Hyperthermia. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3738-9_9
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3738-9_9
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-8327-0
Online ISBN: 978-1-4612-3738-9
eBook Packages: Springer Book Archive